Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Genesis Care North Shore

2 abstracts

Abstract
BGB-11417-203: An ongoing, phase 2 study of sonrotoclax (BGB-11417), a next-generation BCL2 inhibitor, in patients with Waldenström macroglobulinemia.
Org: Lymphoma Research Group, School of Clinical Sciences at Monash Health, Monash University, Hattiesburg Clinic, Genesis Care North Shore, Affiliated Zhongshan Hospital of Fudan University, BeiGene (Beijing) Co, Ltd,
Abstract
Preliminary dose escalation results from a first-in-human, phase I/II study of GB263T, a novel EGFR/cMET/cMET trispecific antibody, in patients with advanced EGFR-mutated (EGFRm) non-small cell lung cancer (NSCLC).
Org: Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China, Genesis Care North Shore, North Shore Health Hub, St Leonards, NSW, Australia,